Particulate tracers for homogeneous immunoassay - comprising antibody, antigen or hapten linked to particulate material without true light absorption

作者: Leroy Olivier Pierre Raymond

DOI:

关键词: HaptenAdsorptionReagentChemistryAnalyteDetection limitImmunoassayChromatographyParticle sizeParticle

摘要: Particulate tracers for use in immunoassays comprise an immunoreactive substance (I) and a particulate label (II), is antibody, antigen or hapten; (II) particle with max. dimension of at least 0.2 micron comprising lyophobic amphilyophilic material having surface some (inherent induced) hydrophilicity without true absorption the visible/near-IR spectrum. The spectra their aggregates aq. medium are same, irrespective size attained by antibody-antigen agglutination reaction. Also claimed photometric immunoassay method determn. analyte, (a) attaching hapten, covalent coupling physical adsorption, to whose micron; (b) contacting resulting tracer analyte medium; (c) irradiating mixt. light wavelength 320-1000 nm; (d) measuring intensity transmitted reaction medium. USE/ADVANTAGE - may be used biological medical analysis, e.g. detection PCR amplification prods. (claimed) serum proteins, drugs such as gentamicin theophylline, pathogens Toxoplasma gondii. simple, uses stable reagents, gives limits ng/ml range good reproducibility.

参考文章(4)
John Bruce C, Marsha Denise Bale C, Harold Chester C, Richard Calvin C, Susan Jean C, Fred Terry C, Ignazio S. C, Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use ,(1991)
Jan H.W. Leuvering, Piet J.H.M. Thal, Menno Van der Waart, Anton H.W.M. Schuurs, A sol particle agglutination assay for human chorionic gonadotrophin Journal of Immunological Methods. ,vol. 45, pp. 183- 194 ,(1981) , 10.1016/0022-1759(81)90212-X
Takashi C, O Daiichi Pure Chemicals Co. Ltd. Takei, Yasuo C, O Daiichi Pure Chemicals Co. Ltd. Maeda, O Daiichi Pure Chem. Co. Ltd Matsumoto, Makiko C, Fujio C, O Daiichi Pure Chemicals Co. Ltd. Sakai, Method for the determination of blood clotting factors and reagent for use therein ,(1988)